Plasticity after allogeneic hematopoietic stem cell transplantation.

Area of Science:

• Hematology
• Regenerative Medicine
• Cell Biology

Background:

• Transplanted hematopoietic stem cells (HSCs) are theorized to possess plasticity, potentially differentiating into non-hematopoietic cell types.
• This concept challenges the traditional hierarchical model of hematopoiesis and suggests broad applications for regenerative cell therapy.
• Evidence of donor cells in recipient tissues post-allogeneic HSC transplantation (HSCT) supports this plasticity theory.

Purpose of the Study:

• To review clinical evidence regarding HSC plasticity in humans following allogeneic HSCT.
• To critically evaluate the phenomenon of non-hematopoietic chimerism and donor cell contribution to tissue repair.
• To discuss controversies surrounding detection methods and the functional implications of observed donor cell presence.

Main Methods:

• Focus on clinical studies involving allogeneic HSCT in human recipients.
• Summarize published data on non-hematopoietic chimerism and tissue repair.
• Analyze methodologies used for detecting donor-derived non-hematopoietic cells.

Main Results:

• The potential for HSCs to transdifferentiate into non-hematopoietic lineages remains debated.
• Alternative explanations, such as cell fusion, are proposed to explain donor cell presence in non-hematopoietic tissues.
• Controversies exist regarding the accuracy of methods used to identify donor-derived cells.

Conclusions:

• Definitive proof of HSC transdifferentiation capacity across lineage barriers is lacking.
• The observed presence of donor cells in non-hematopoietic tissues may result from mechanisms other than true transdifferentiation.
• Further research is needed to clarify the mechanisms and functional significance of donor cell engraftment in non-hematopoietic tissues.